Retraction notice to “Geniposide plays anti-tumor effects by down-regulation of microRNA-224 in HepG2 and Huh7 cell lines” [Experimental and Molecular Pathology 112 (2020) 104349]
- DOI
- 10.1016/j.yexmp.2022.104775
- Published
- 2022-06
- Container
- Experimental and Molecular Pathology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.yexmp.2022.104775,
title = {Retraction notice to “Geniposide plays anti-tumor effects by down-regulation of microRNA-224 in HepG2 and Huh7 cell lines” [Experimental and Molecular Pathology 112 (2020) 104349]},
author = {Xue Yu and Yu Wang and Shujun Tao and Shulun Sun},
year = {2022},
journal = {Experimental and Molecular Pathology},
doi = {10.1016/j.yexmp.2022.104775},
url = {https://doi.org/10.1016/j.yexmp.2022.104775}
}RIS
TY - JOUR TI - Retraction notice to “Geniposide plays anti-tumor effects by down-regulation of microRNA-224 in HepG2 and Huh7 cell lines” [Experimental and Molecular Pathology 112 (2020) 104349] AU - Xue Yu AU - Yu Wang AU - Shujun Tao AU - Shulun Sun PY - 2022 JO - Experimental and Molecular Pathology DO - 10.1016/j.yexmp.2022.104775 UR - https://doi.org/10.1016/j.yexmp.2022.104775 ER -
APA
Yu, X., Wang, Y., Tao, S., & Sun, S. (2022). Retraction notice to “Geniposide plays anti-tumor effects by down-regulation of microRNA-224 in HepG2 and Huh7 cell lines” [Experimental and Molecular Pathology 112 (2020) 104349]. Experimental and Molecular Pathology. https://doi.org/10.1016/j.yexmp.2022.104775
Source records
- crossref · retrieved 2026-09-26T05:19:39.971Z